This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


New reports outline bold goals for U.S. bioeconomy

white house
Credit: Unsplash/CC0 Public Domain

On March 22, the White House Office of Science and Technology Policy released a series of five reports authored by federal agencies, including the U.S. National Science Foundation, outlining bold research and development goals for the U.S. bioeconomy.

The NSF-led report lays out the research and infrastructure investments needed to harness the potential of recent developments in biotechnology, much of which was supported by the agency, and to advance new innovations across all sectors of the bioeconomy.

"NSF has supported discoveries in biotechnology for decades resulting in discoveries like PCR which powered the COVID-19 tests to CRISPR gene editing, new polymers and advances in ," said NSF Director Sethuraman Panchanathan. "We have seen the tremendous power of synergized support for basic biological research and use-inspired efforts in all fields of science and engineering. To create the bioeconomy of the future, we need to further strengthen this innovation at speed and scale along multiple dimensions."

The report, "Biotechnology and Biomanufacturing R&D to Further Crosscutting Advances," focuses on bold goals and research and development needs within six themes: leveraging biodiversity; enhancing prediction and design of biological systems; expanding the capability to build and measure systems; advancing the ability to scale-up novel biotechnologies; accelerating innovation in biomanufacturing approaches; and co-generating and translating biotechnology. Achieving the bold goals outlined in these areas will require a whole-of-government effort, including alignment with and investments from other and the , in addition to currently funded R&D efforts.

Other reports, all of which NSF contributed to, focus on advancements and investments in and biomanufacturing to achieve medical breakthroughs; address the causes of and adapt to ; spur food and agriculture innovation; and strengthen the resilience of U.S. supply chains.

More information: Full Report: Bold Goals for U.S. Biotechnology and Biomanufacturing

Citation: New reports outline bold goals for U.S. bioeconomy (2023, March 23) retrieved 14 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New partnership could put University of Minnesota at center of biomanufacturing industry


Feedback to editors